1.
The Community shall purchase as soon as possible the following strains of foot-and-mouth disease antigen:
–
A Iran 96: 1000000 doses,
–
A Iran 99: 1000000 doses,
–
A Malaysia 97: 500000 doses,
–
SAT1: 500000 doses,
–
SAT2 (Southern Africa): 500000 doses,
–
SAT2 (East Africa): 500000 doses,
–
SAT3: 500000 doses.
2.
The Community shall make arrangements for formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens referred to in paragraph 1.
3.
The maximum cost of the measures referred to in paragraphs 1 and 2 shall be up to EUR 2,5 million.
4.
The action referred to in paragraph 3 shall be organised by the Commission before 31 December 1999.